Portola Antidote Success $PTLA $XHS

Portola Pharmaceuticals, got positive results for a antidote test, which evaluated the safety and efficacy of andexanet alfa, an investigational antidote, with the Factor Xa inhibitor Eliquis (apixaban) in healthy volunteers. View the full release here.

Portola Antidote Success $PTLA $XHS Read More »